Literature DB >> 22468030

Serum insulin-like growth factor-1 measurements in dogs: performance characteristics of an automated assay and study of some sources of variation.

Asta Tvarijonaviciute1, Fernando Tecles, José M Carrillo, José M Carillo, Monica Rubio, José J Ceron.   

Abstract

The aim of this study was to evaluate the performance characteristics of an automated immunoassay for canine insulin-like growth factor 1 (IGF-1) measurement and to investigate the possible effects of some sources of variation, such as diurnal variations, feeding/fasting cycles, and glucocorticoid administration, in dogs. The immunoassay evaluated had an adequate analytical performance with intra- and inter-assay coefficients of variation (CVs) lower than 10%, linear regression equations with correlation coefficients of 0.9993 and 0.9988 after serial dilutions, and a limit of quantification of 7.1 ng/mL that was even lower than that reported by the manufacturer. The assay was significantly affected by hemolysis and lipemia producing a significant decrease in IGF-1 concentrations, but not by bilirubinemia.Serum IGF-1 concentrations did not show significant diurnal changes in fed or fasted dogs and were not affected by glucocorticoid administration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22468030      PMCID: PMC3187639     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  19 in total

Review 1.  Serum levels of insulin-like growth factor I and its binding proteins in health and disease.

Authors:  Anders Juul
Journal:  Growth Horm IGF Res       Date:  2003-08       Impact factor: 2.372

2.  Rapid weight loss with a high-protein low-energy diet allows the recovery of ideal body composition and insulin sensitivity in obese dogs.

Authors:  Géraldine Blanchard; Patrick Nguyen; Constance Gayet; Isabelle Leriche; Brigitte Siliart; Bernard-Marie Paragon
Journal:  J Nutr       Date:  2004-08       Impact factor: 4.798

3.  Effects of different glucocorticoid treatments on serum acute phase proteins in dogs.

Authors:  S Martínez-Subiela; P J Ginel; J J Cerón
Journal:  Vet Rec       Date:  2004-06-26       Impact factor: 2.695

4.  The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers.

Authors:  J P Miell; A M Taylor; J Jones; J M Holly; R C Gaillard; F P Pralong; R J Ross; W F Blum
Journal:  J Endocrinol       Date:  1993-03       Impact factor: 4.286

Review 5.  The somatomedin hypothesis: 2001.

Authors:  D Le Roith; C Bondy; S Yakar; J L Liu; A Butler
Journal:  Endocr Rev       Date:  2001-02       Impact factor: 19.871

6.  Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer.

Authors:  Felisbina L Queiroga; Dolores Pérez-Alenza; Gema Silvan; Laura Peña; Carlos S Lopes; Juan C Illera
Journal:  Res Vet Sci       Date:  2010-04-08       Impact factor: 2.534

7.  Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy.

Authors:  M Gourmelen; F Girard; M Binoux
Journal:  J Clin Endocrinol Metab       Date:  1982-05       Impact factor: 5.958

8.  Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids.

Authors:  O D Wolthers; M Hansen; A Juul; H K Nielsen; S Pedersen
Journal:  Pediatr Res       Date:  1997-01       Impact factor: 3.756

9.  Reference ranges for serum IGF-1 and IGFBP-3 levels in Chinese children during childhood and adolescence.

Authors:  Shanshan Xu; Xuefan Gu; Hui Pan; Huijuan Zhu; Fengying Gong; Yufeng Li; Yanmei Xing
Journal:  Endocr J       Date:  2010-01-06       Impact factor: 2.349

10.  The insulin-like growth factor axis and collagen turnover during prednisolone treatment.

Authors:  O D Wolthers; A Juul; M Hansen; J Müller; S Pedersen
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

View more
  6 in total

1.  Effect of neuroactive nutritional supplementation on body weight and composition in growing puppies.

Authors:  Wei Wang; Melissa Brooks; Cari Gardner; Norton Milgram
Journal:  J Nutr Sci       Date:  2017-11-23

2.  Restored vision in a young dog following corticosteroid treatment of presumptive hypophysitis.

Authors:  Nina Marie Rzechorzek; Tiziana Liuti; Catherine Stalin; Katia Marioni-Henry
Journal:  BMC Vet Res       Date:  2017-02-28       Impact factor: 2.741

3.  Fasting Reduces the Incidence of Delayed-Type Vomiting Associated with Doxorubicin Treatment in Dogs with Lymphoma.

Authors:  Sita S Withers; Philip H Kass; Carlos O Rodriguez; Katherine A Skorupski; Danielle O'Brien; Teri A Guerrero; Kristen D Sein; Robert B Rebhun
Journal:  Transl Oncol       Date:  2014-05-12       Impact factor: 4.243

4.  Changes in biochemical analytes in female dogs with subclinical Ancylostoma spp. infection.

Authors:  Elizabeth M S Schmidt; Asta Tvarijonaviciute; Silvia Martinez-Subiela; José J Cerón; Peter D Eckersall
Journal:  BMC Vet Res       Date:  2016-09-13       Impact factor: 2.741

5.  Can Plasma Rich in Growth Factors Be Safe for Parental Use? A Safety Study in the Canine Model.

Authors:  Elena Damiá; Deborah Chicharro; Mónica Rubio; José María Carrillo; Joaquín Sopena; Belén Cuervo; Sergio López; José Manuel Vilar
Journal:  Int J Mol Sci       Date:  2018-09-11       Impact factor: 5.923

6.  An investigation on the relevance of prolactin, insulin-like growth factor-1 and 25-hydroxyvitamin D3 (25-OHD3 ) in canine benign prostatic hyperplasia in a predisposed breed model.

Authors:  Franziska Werhahn Beining; Marion Schmicke; Mirja Wilkens; Karola Wolf; Karl Rohn; Anne-Rose Günzel-Apel
Journal:  Vet Med Sci       Date:  2021-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.